Evidence map›Paper›PMID 31670581›Full record

ArticleThe British journal of radiology2020

Image-guidance triggered adaptive replanning of radiation therapy for locally advanced lung cancer: an evaluation of cases requiring plan adaptation.

Sarit Appel, Jair Bar, Dror Alezra, Maoz Ben-Ayun, Tatiana Rabin-Alezra, Nir Honig, Tamar Katzman, Sumit Chatterji, Zvi Symon, Yaacov Richard Lawrence

Abstract read
In one paragraph

Article in The British journal of radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Are offline ART decisions for NSCLC impacted by the type of dose calculation algorithm?Technical innovations & patient support in radiation oncology · 2024
    Article
  7. Article
  8. Article
  9. New developments in locally advanced nonsmall cell lung cancer.European respiratory review : an official journal of the European Respiratory Society · 2021
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sarit AppelRadiation Oncology, Institute Of Oncology, Chaim Sheba Medical Center affiliated to Tel Aviv University, Sackler faculty of medicine, Ramat Gan, Israel.
Jair BarMedical Oncology, Institute of Oncology, Chaim Sheba Medical Center, affiliated to Tel Aviv University, Sackler faculty of medicine, Ramat Gan, Israel.
Dror AlezraRadiation Oncology, Institute Of Oncology, Chaim Sheba Medical Center affiliated to Tel Aviv University, Sackler faculty of medicine, Ramat Gan, Israel.
Maoz Ben-AyunRadiation Oncology, Institute Of Oncology, Chaim Sheba Medical Center affiliated to Tel Aviv University, Sackler faculty of medicine, Ramat Gan, Israel.
Tatiana Rabin-AlezraRadiation Oncology, Sourasky Medical Center, Tel Aviv, Israel.
Nir HonigRadiation Oncology, Institute Of Oncology, Chaim Sheba Medical Center affiliated to Tel Aviv University, Sackler faculty of medicine, Ramat Gan, Israel.
Tamar KatzmanRadiation Oncology, Institute Of Oncology, Chaim Sheba Medical Center affiliated to Tel Aviv University, Sackler faculty of medicine, Ramat Gan, Israel.
Sumit ChatterjiDepartment of Pulmonology, Chaim Sheba Medical Center affiliated to Tel Aviv University, Sackler faculty of medicine, Israel, Ramat Gan, Israel.
Zvi SymonRadiation Oncology, Institute Of Oncology, Chaim Sheba Medical Center affiliated to Tel Aviv University, Sackler faculty of medicine, Ramat Gan, Israel.
Yaacov Richard LawrenceRadiation Oncology, Institute Of Oncology, Chaim Sheba Medical Center affiliated to Tel Aviv University, Sackler faculty of medicine, Ramat Gan, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAnatomic changes may occur during chemoradiation treatment for lung cancers, requiring adaptive replanning. Here we characterize these cases.

methodsWe retrospectively studied lung cancer cases that underwent resimulation and adaptive replanning during 1/2016-3/2019. We compared first and second CT-simulation regarding tumor location, timing of change, tumor volume, anatomical alteration and change in simulation technique. We also compared dosimetric parameters between the plans, recorded local control, and overall survival outcomes.

resultsOut of 281 patients, 58 underwent replanning (20.6%). Histology included small cell (22.4%) and non-small cell (77.6%). Stage III was in 91.4%. Mean radiation dose of 59.4 Gray (Gy) (range 50-66Gy).Tumor location was peribronchial in 53.5%. Timing of replanning was in the first, second and final third of the treatment course in 26%, 43% and 31% respectively. Changes in gross tumor volume were observed in 74%; mean gross tumor volume was 276.7cc

conclusionAdaptive replanning of radiation was performed in a fifth of locally advanced lung cancer patients. In most cases tumor volume decreased, or atelectasis resolved, causing mediastinal shifts, which, if unidentified and left uncorrected, may have led to local failure and increased toxicity. The heart V40Gy was reduced significantly in all cases, but significant reduction in lung doses was evident only if simulation technique was altered. ADVANCES IN KNOWLEDGE: In locally advanced lung cancer image-guidance with cone beam CT can detect significant mediastinal shifts and gross tumor volume changes that raise the need for adaptive replanning. Image guidance-triggered adaptive replanning should be added to the armament of advanced radiation treatment planning in locally advanced lung cancer.

Indexed as

AdultAgedAged, 80 and overAlgorithmsChemoradiotherapyFemaleHumansLung NeoplasmsMaleMiddle AgedNeoplasm StagingRadiotherapy DosageRadiotherapy, Image-GuidedRadiotherapy Planning, Computer-AssistedSurvival RateTomography, X-Ray Computed

Identifiers

PMID31670581
PMCPMC6948072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.